Literature DB >> 20464461

In vivo, in situ imaging of microneedle insertion into the skin of human volunteers using optical coherence tomography.

Siôn A Coulman1, James C Birchall, Aneesh Alex, Marc Pearton, Bernd Hofer, Conor O'Mahony, Wolfgang Drexler, Boris Považay.   

Abstract

PURPOSE: To gather sub-surface in situ images of microneedle-treated human skin, in vivo, using optical coherence tomography (OCT). This is the first study to utilise OCT to investigate the architectural changes that are induced in skin following microneedle application.
METHODS: Steel, silicon and polymer microneedle devices, with different microneedle arrangements and morphologies, were applied to two anatomical sites in human volunteers following appropriate ethical approval. A state-of-the-art ultrahigh resolution OCT imaging system operating at 800 nm wavelength and <3 µm effective axial resolution was used to visualise the microneedle-treated area during insertion and/or following removal of the device, without any tissue processing.
RESULTS: Transverse images of a microneedle device, in situ, were captured by the OCT system and suggest that the stratified skin tissue is compressed during microneedle application. Following removal of the device, the created microchannels collapse within the in vivo environment and, therefore, for all studied devices, microconduit dimensions are markedly smaller than the microneedle dimensions.
CONCLUSIONS: Microchannels created in the upper skin layers by microneedles are less invasive than previous histology predicts. OCT has the potential to play a highly influential role in the future development of microneedle devices and other transdermal delivery systems.

Entities:  

Mesh:

Year:  2010        PMID: 20464461     DOI: 10.1007/s11095-010-0167-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  49 in total

1.  Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies.

Authors:  Devin V McAllister; Ping M Wang; Shawn P Davis; Jung-Hwan Park; Paul J Canatella; Mark G Allen; Mark R Prausnitz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

2.  Compact, low-cost Ti:Al2O3 laser for in vivo ultrahigh-resolution optical coherence tomography.

Authors:  A Unterhuber; B Povazay; B Hermann; H Sattmann; W Drexler; V Yakovlev; G Tempea; C Schubert; E M Anger; P K Ahnelt; M Stur; J E Morgan; A Cowey; G Jung; T Le; A Stingl
Journal:  Opt Lett       Date:  2003-06-01       Impact factor: 3.776

3.  Transdermal delivery of desmopressin using a coated microneedle array patch system.

Authors:  Michel Cormier; Bonny Johnson; Mahmoud Ameri; Kofi Nyam; Luz Libiran; Dee Dee Zhang; Pete Daddona
Journal:  J Control Release       Date:  2004-07-07       Impact factor: 9.776

Review 4.  Microneedles for transdermal drug delivery.

Authors:  Mark R Prausnitz
Journal:  Adv Drug Deliv Rev       Date:  2004-03-27       Impact factor: 15.470

5.  Cutaneous DNA delivery and gene expression in ex vivo human skin explants via wet-etch micro-fabricated micro-needles.

Authors:  James Birchall; Sion Coulman; Marc Pearton; Chris Allender; Keith Brain; Alexander Anstey; Chris Gateley; Nicolle Wilke; Anthony Morrissey
Journal:  J Drug Target       Date:  2005-08       Impact factor: 5.121

6.  Coated microneedles for transdermal delivery.

Authors:  Harvinder S Gill; Mark R Prausnitz
Journal:  J Control Release       Date:  2006-10-24       Impact factor: 9.776

7.  Cutaneous gene expression of plasmid DNA in excised human skin following delivery via microchannels created by radio frequency ablation.

Authors:  James Birchall; Sion Coulman; Alexander Anstey; Chris Gateley; Helen Sweetland; Amikam Gershonowitz; Lewis Neville; Galit Levin
Journal:  Int J Pharm       Date:  2006-02-15       Impact factor: 5.875

8.  Improved influenza vaccination in the skin using vaccine coated microneedles.

Authors:  Yeu-Chun Kim; Fu-Shi Quan; Dae-Goon Yoo; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  Vaccine       Date:  2009-09-15       Impact factor: 3.641

9.  Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.

Authors:  Yeu-Chun Kim; Fu-Shi Quan; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  J Control Release       Date:  2009-10-17       Impact factor: 9.776

10.  Characterization of solid maltose microneedles and their use for transdermal delivery.

Authors:  Chandra Sekhar Kolli; Ajay K Banga
Journal:  Pharm Res       Date:  2007-06-28       Impact factor: 4.200

View more
  27 in total

1.  Characterization of microchannels created by metal microneedles: formation and closure.

Authors:  Haripriya Kalluri; Chandra Sekhar Kolli; Ajay K Banga
Journal:  AAPS J       Date:  2011-07-06       Impact factor: 4.009

Review 2.  Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation.

Authors:  Rebecca E M Lutton; Jessica Moore; Eneko Larrañeta; Stephen Ligett; A David Woolfson; Ryan F Donnelly
Journal:  Drug Deliv Transl Res       Date:  2015-08       Impact factor: 4.617

3.  Large Size Microneedle Patch to Deliver Lidocaine through Skin.

Authors:  Himanshu Kathuria; Hairui Li; Jing Pan; Seng Han Lim; Jaspreet Singh Kochhar; Chunyong Wu; Lifeng Kang
Journal:  Pharm Res       Date:  2016-07-11       Impact factor: 4.200

4.  Optimization of impedance spectroscopy techniques for measuring cutaneous micropore formation after microneedle treatment in an elderly population.

Authors:  Megan N Kelchen; Grant O Holdren; Matthew J Farley; M Bridget Zimmerman; Janet A Fairley; Nicole K Brogden
Journal:  Pharm Res       Date:  2014-06-20       Impact factor: 4.200

5.  Laser facilitates week-long sustained transdermal drug delivery at high doses.

Authors:  Prateek Kakar; Zhuofan Li; Yibo Li; Yan Cao; Xinyuan Chen
Journal:  J Control Release       Date:  2020-01-07       Impact factor: 9.776

6.  Microneedle-assisted percutaneous delivery of naltrexone hydrochloride in yucatan minipig: in vitro-in vivo correlation.

Authors:  Mikolaj Milewski; Kalpana S Paudel; Nicole K Brogden; Priyanka Ghosh; Stan L Banks; Dana C Hammell; Audra L Stinchcomb
Journal:  Mol Pharm       Date:  2013-09-23       Impact factor: 4.939

7.  Kinetics of skin resealing after insertion of microneedles in human subjects.

Authors:  Jyoti Gupta; Harvinder S Gill; Samantha N Andrews; Mark R Prausnitz
Journal:  J Control Release       Date:  2011-05-26       Impact factor: 9.776

8.  Microneedle delivery of plasmid DNA to living human skin: Formulation coating, skin insertion and gene expression.

Authors:  Marc Pearton; Verena Saller; Sion A Coulman; Chris Gateley; Alexander V Anstey; Vladimir Zarnitsyn; James C Birchall
Journal:  J Control Release       Date:  2012-04-10       Impact factor: 9.776

9.  Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-concept.

Authors:  Rosalind H E Chong; Emilio Gonzalez-Gonzalez; Maria F Lara; Tycho J Speaker; Christopher H Contag; Roger L Kaspar; Sion A Coulman; Rachel Hargest; James C Birchall
Journal:  J Control Release       Date:  2013-01-08       Impact factor: 9.776

10.  Host responses in human skin after conventional intradermal injection or microneedle administration of virus-like-particle influenza vaccine.

Authors:  Marc Pearton; Daniela Pirri; Sang-Moo Kang; Richard W Compans; James C Birchall
Journal:  Adv Healthc Mater       Date:  2013-04-08       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.